Clinical Trial Update: Open-Label Study of Dimethyl Fumarate in Adults With Type 1 Diabetes [Phase 2, Phase 3]

View source ↗

Summary

An open-label Phase 2/3 study of dimethyl fumarate in adults with Type 1 Diabetes is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Tecfidera (dimethyl fumarate)

Snippet

Sponsor: Nanjing Medical University | Conditions: Type 1 Diabetes Mellitus | Phase 2, Phase 3 | Status: RECRUITING